Whan In Pharm Co.,Ltd. (KRX:016580)
South Korea
· Delayed Price · Currency is KRW 11,570
-10 (-0.09%)
Last updated: Dec 5, 2025, 10:52 AM KST
Whan In Pharm Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 177,251 | 180,304 | 229,617 | 268,700 | 271,754 | 254,960 | Upgrade
|
| Market Cap Growth | -12.18% | -21.48% | -14.54% | -1.12% | 6.59% | 8.09% | Upgrade
|
| Enterprise Value | 118,322 | 129,280 | 155,357 | 180,073 | 139,039 | 131,637 | Upgrade
|
| Last Close Price | 11610.00 | 11810.00 | 14667.72 | 16819.00 | 16719.35 | 15419.51 | Upgrade
|
| PE Ratio | 11.86 | 7.71 | 7.71 | 11.23 | 10.19 | 10.90 | Upgrade
|
| PS Ratio | 0.69 | 0.70 | 1.00 | 1.35 | 1.53 | 1.49 | Upgrade
|
| PB Ratio | 0.45 | 0.48 | 0.64 | 0.81 | 0.86 | 0.86 | Upgrade
|
| P/TBV Ratio | 0.46 | 0.49 | 0.65 | 0.81 | 0.87 | 0.87 | Upgrade
|
| P/FCF Ratio | 31.22 | - | - | - | 8.79 | 17.27 | Upgrade
|
| P/OCF Ratio | 17.20 | 8.71 | 9.90 | 15.95 | 7.69 | 11.21 | Upgrade
|
| EV/Sales Ratio | 0.46 | 0.50 | 0.67 | 0.91 | 0.78 | 0.77 | Upgrade
|
| EV/EBITDA Ratio | 5.11 | 4.31 | 4.22 | 5.20 | 3.92 | 4.05 | Upgrade
|
| EV/EBIT Ratio | 8.88 | 6.01 | 5.15 | 6.04 | 4.45 | 4.63 | Upgrade
|
| EV/FCF Ratio | 20.84 | - | - | - | 4.50 | 8.91 | Upgrade
|
| Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | Upgrade
|
| Debt / EBITDA Ratio | 0.03 | 0.01 | 0.02 | 0.01 | 0.05 | 0.07 | Upgrade
|
| Debt / FCF Ratio | 0.13 | - | - | - | 0.06 | 0.15 | Upgrade
|
| Asset Turnover | 0.59 | 0.63 | 0.60 | 0.55 | 0.52 | 0.54 | Upgrade
|
| Inventory Turnover | 2.20 | 2.62 | 2.89 | 2.87 | 2.58 | 2.79 | Upgrade
|
| Quick Ratio | 3.24 | 3.03 | 3.93 | 5.03 | 6.77 | 6.77 | Upgrade
|
| Current Ratio | 5.56 | 4.75 | 5.30 | 6.22 | 7.85 | 8.02 | Upgrade
|
| Return on Equity (ROE) | 3.95% | 6.37% | 8.60% | 7.29% | 8.62% | 8.12% | Upgrade
|
| Return on Assets (ROA) | 1.80% | 3.25% | 4.89% | 5.16% | 5.73% | 5.60% | Upgrade
|
| Return on Capital (ROIC) | 2.02% | 3.65% | 5.44% | 5.71% | 6.33% | 6.18% | Upgrade
|
| Return on Capital Employed (ROCE) | 3.10% | 5.60% | 8.40% | 8.80% | 9.70% | 9.40% | Upgrade
|
| Earnings Yield | 8.56% | 12.97% | 12.97% | 8.90% | 9.81% | 9.17% | Upgrade
|
| FCF Yield | 3.20% | -3.70% | -3.19% | -6.25% | 11.38% | 5.79% | Upgrade
|
| Dividend Yield | 2.58% | 2.54% | 2.04% | 1.78% | 1.79% | 1.95% | Upgrade
|
| Payout Ratio | 30.20% | 19.59% | 15.38% | 19.15% | 17.18% | 19.58% | Upgrade
|
| Buyback Yield / Dilution | -1.53% | - | - | - | - | - | Upgrade
|
| Total Shareholder Return | 1.06% | 2.54% | 2.04% | 1.78% | 1.79% | 1.95% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.